2.99BMarket Cap
LossP/E TTM
CLDX Balance Sheet
You can check out the annual or quarterly balance sheets of Celldex Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing CLDX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Celldex Therapeutics Inc Have?
In its most recent quarterly, Celldex Therapeutics Inc had 35.73M in cash and cash equivalents.
How Much Are Celldex Therapeutics Inc's Total Liabilities?
Celldex Therapeutics Inc reported 55.82M in total liabilities as of the latest reported quarter, including 50.99M in current liabilities and 4.83M in non-current liabilities.
What Are Celldex Therapeutics Inc's Total Assets?
As of the latest reported quarter, Celldex Therapeutics Inc's total assets were 582.98M, consisting of 534.66M in current assets and 48.32M in non-current assets.
How Much Shareholders' Equity Does Celldex Therapeutics Inc Have?
Celldex Therapeutics Inc reported 527.16M in total shareholders' equity as of the latest reported quarter.